INTEGRA LIFESCIENCES HOLDINGS CORP Finite-Lived Intangible Assets, Accumulated Amortization
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) had Finite-Lived Intangible Assets, Accumulated Amortization of $908.23 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2026-07-29
- 2026-06-30: Finite-Lived Intangible Assets, Accumulated Amortization $908.23M.
- 2026-03-31: Finite-Lived Intangible Assets, Accumulated Amortization $883.31M.
- 2025-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $858.07M.
- 2025-09-30: Finite-Lived Intangible Assets, Accumulated Amortization $830.20M.
| Period end | Finite-Lived Intangible Assets, Accumulated Amortization | Finite-Lived Intangible Assets, Accumulated Amortization as first filed |
|---|---|---|
| 2026-06-30 | $908.23M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $883.31M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $858.07M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $830.20M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $804.10M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $762.57M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $732.18M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $715.41M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $682.80M 10-Q · filed 2024-07-29 | |
| 2024-03-31 | $657.28M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $662.00M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $632.96M 10-Q · filed 2023-10-25 | |
| 2023-06-30 | $615.12M 10-Q · filed 2023-07-27 | |
| 2023-03-31 | $592.60M 10-Q · filed 2023-04-26 | |
| 2022-12-31 | $570.92M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $544.42M 10-Q · filed 2022-10-26 | |
| 2022-06-30 | $529.85M 10-Q · filed 2022-07-27 | |
| 2022-03-31 | $520.22M 10-Q · filed 2022-04-27 | |
| 2021-12-31 | $501.32M 10-K · filed 2023-02-22 | |
| 2021-09-30 | $480.43M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $461.62M 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $440.22M 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $431.65M 10-K · filed 2022-02-24 | $434.95M 10-K · filed 2021-02-23 |
| 2020-09-30 | $418.80M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $422.76M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $401.48M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $384.20M 10-K · filed 2021-02-23 | |
| 2019-09-30 | $364.95M 10-Q · filed 2019-10-25 | |
| 2019-06-30 | $350.04M 10-Q · filed 2019-07-25 | |
| 2019-03-31 | $335.64M 10-Q · filed 2019-04-29 | |
| 2018-12-31 | $319.43M 10-K · filed 2020-02-21 | |
| 2018-09-30 | $303.61M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $289.01M 10-Q · filed 2018-07-26 | |
| 2018-03-31 | $274.07M 10-Q · filed 2018-04-26 | |
| 2017-12-31 | $256.99M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $244.43M 10-Q · filed 2017-10-26 | |
| 2017-06-30 | $232.66M 10-Q · filed 2017-07-26 | |
| 2017-03-31 | $218.61M 10-Q · filed 2017-04-26 | |
| 2016-12-31 | $207.16M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $198.40M 10-Q · filed 2016-10-28 | |
| 2016-06-30 | $188.03M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $178.34M 10-Q · filed 2016-04-27 | |
| 2015-12-31 | $166.71M 10-K · filed 2017-02-23 | |
| 2015-09-30 | $156.65M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $192.52M 10-Q · filed 2015-07-31 | |
| 2015-03-31 | $185.60M 10-Q · filed 2015-05-01 | |
| 2014-12-31 | $137.63M 10-K · filed 2016-02-26 | $180.19M 10-K · filed 2015-02-27 |
| 2014-09-30 | $173.16M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $167.32M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $159.17M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $151.86M 10-K · filed 2015-02-27 | |
| 2013-09-30 | $147.12M 10-Q · filed 2013-10-30 | |
| 2013-06-30 | $141.52M 10-Q/A · filed 2013-08-02 | |
| 2013-03-31 | $137.12M 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $132.65M 8-K · filed 2014-06-20 | |
| 2012-09-30 | $126.40M 10-Q · filed 2012-10-24 | |
| 2012-06-30 | $119.72M 10-Q · filed 2012-07-31 | |
| 2012-03-31 | $114.25M 10-Q · filed 2012-04-26 | |
| 2011-12-31 | $113.50M 10-K · filed 2013-02-26 | |
| 2011-09-30 | $108.79M 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $106.39M 10-Q · filed 2011-08-01 | |
| 2010-12-31 | $94.22M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |